| nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
| 1 |
Caregiver-guided pain coping skills training for patients with advanced cancer: Background, design, and challenges for the CaringPals study
|
Porter, Laura S
|
|
2019
|
16 |
3 |
p. 263-272
|
artikel
|
| 2 |
Commentary on King-Kallimanis et al.: Inadequate measurement of symptomatic adverse events in immunotherapy registration trials
|
Basch, Ethan
|
|
2019
|
16 |
3 |
p. 327-328
|
artikel
|
| 3 |
Comprehension and recall from the informed consent process by phase I healthy volunteers before dose administration
|
Tadros, Rami
|
|
2019
|
16 |
3 |
p. 283-289
|
artikel
|
| 4 |
Determination of fasiglifam-induced liver toxicity: Insights from the data monitoring committee of the fasiglifam clinical trials program
|
Shavadia, Jay S
|
|
2019
|
16 |
3 |
p. 253-262
|
artikel
|
| 5 |
Establishing an electronic health record–supported approach for outreach to and recruitment of persons at high risk of type 2 diabetes in clinical trials: The vitamin D and type 2 diabetes (D2d) study experience
|
Aroda, Vanita R
|
|
2019
|
16 |
3 |
p. 306-315
|
artikel
|
| 6 |
Exploring the roots of clinical trial methodology in medieval Islamic medicine
|
Zarvandi, Mahdi
|
|
2019
|
16 |
3 |
p. 316-321
|
artikel
|
| 7 |
Globalization of clinical trials: Variation in estimated regional costs of pivotal trials, 2015–2016
|
Qiao, Yao
|
|
2019
|
16 |
3 |
p. 329-333
|
artikel
|
| 8 |
Improving pragmatic clinical trial design using real-world data
|
Shortreed, Susan M
|
|
2019
|
16 |
3 |
p. 273-282
|
artikel
|
| 9 |
Inference on covariate effect types for treatment effectiveness in a randomized trial with a binary outcome
|
Chiba, Yasutaka
|
|
2019
|
16 |
3 |
p. 237-245
|
artikel
|
| 10 |
Merged block randomisation: A novel randomisation procedure for small clinical trials
|
van der Pas, Stéphanie L
|
|
2019
|
16 |
3 |
p. 246-252
|
artikel
|
| 11 |
Patient reported outcomes in anti-PD-1/PD-L1 inhibitor immunotherapy registration trials: FDA analysis of data submitted and future directions
|
King-Kallimanis, Bellinda L
|
|
2019
|
16 |
3 |
p. 322-326
|
artikel
|
| 12 |
Sample size calculation for stepped-wedge cluster-randomized trials with more than two levels of clustering
|
Teerenstra, Steven
|
|
2019
|
16 |
3 |
p. 225-236
|
artikel
|
| 13 |
There is still a place for significance testing in clinical trials
|
Cook, Jonathan A
|
|
2019
|
16 |
3 |
p. 223-224
|
artikel
|
| 14 |
Transitioning to the National Institutes of Health single institutional review board model: Piloting the use of the Streamlined, Multi-site, Accelerated Resources for Trials IRB Reliance
|
Vardeny, Orly
|
|
2019
|
16 |
3 |
p. 290-296
|
artikel
|
| 15 |
Use of telephone and web interfaces of interactive response technology at clinical investigator sites in clinical trials
|
Saarela, Anna-Leena
|
|
2019
|
16 |
3 |
p. 297-305
|
artikel
|
Tijdschrift beschrijving